Characteristics | Total (%) | Non-response group (%) | Response group (%) | P value |
---|---|---|---|---|
Age | 0.884 | |||
 ≤ 60 | 25 (51) | 13 (54) | 12 (48) |  |
 > 60 | 24 (49) | 11 (46) | 13 (52) |  |
Sex | 0.924 | |||
 Male | 34 (69) | 16 (67) | 18 (72) |  |
 Female | 15 (31) | 8 (33) | 7 (28) |  |
Site | 0.291 | |||
 U | 11 (22) | 6 (25) | 5 (20) |  |
 M | 15 (31) | 8 (33) | 7 (28) |  |
 L | 16 (33) | 9 (38) | 7 (28) |  |
 Overlapping | 7 (14) | 1 (4) | 6 (24) |  |
Histology | 0.479 | |||
 Adenocarcinoma | 11 (22) | 4 (17) | 7 (28) |  |
 SRC | 6 (12) | 4 (17) | 2 (8) |  |
 Other | 32 (65) | 16 (67) | 16 (64) |  |
Regimen | 0.686 | |||
 DOS | 10 (20) | 6 (25) | 4 (16) |  |
 XELOX | 23 (47) | 11 (46) | 12 (48) |  |
 Other | 16 (33) | 5 (21) | 8 (32) |  |